SCHEMBL4582694

SCHEMBL4582694

CC=CCCCCCC=CC(=O)OCC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.66
ALDH1A1 P00352 2/20 0.58
FAAH O00519 2/20 0.47
HCAR2 Q8TDS4 1/20 0.47
ALOX15 P16050 2/20 0.46
HSD17B10 Q99714 2/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
PPARG P37231 2/20 0.41
PPARA Q07869 2/20 0.41
NR1I2 O75469 1/20 0.41
PGR P06401 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
PTGS2 P35354 1/20 0.41
PDE4D Q08499 1/20 0.41
GMNN O75496 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11553345 1.00 MAPT (0.66) MAPTALDH1A1FAAHHCAR2ALOX15
SCHEMBL4935160 1.00 MAPT (0.66) MAPTALDH1A1FAAHHCAR2ALOX15
SCHEMBL4937475 0.98 MAPT (0.68) MAPTALDH1A1FAAHHCAR2ALOX15
SCHEMBL4937473 0.98 MAPT (0.68) MAPTALDH1A1FAAHHCAR2ALOX15
SCHEMBL4937290 0.94 MAPT (0.73) MAPTALDH1A1FAAHHCAR2ALOX15
SCHEMBL4937283 0.94 MAPT (0.73) MAPTALDH1A1FAAHHCAR2ALOX15
SCHEMBL25404144 0.87 MAPT (0.68) MAPTALDH1A1FAAHHCAR2ALOX15
SCHEMBL11795363 0.87 MAPT (0.68) MAPTALDH1A1FAAHHCAR2ALOX15
SCHEMBL873713 0.87 MAPT (0.68) MAPTALDH1A1FAAHHCAR2ALOX15
SCHEMBL21027289 0.87 MAPT (0.68) MAPTALDH1A1FAAHHCAR2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080076699-A1 Deconjugated alkadienoic acid esters as fragrances and or aroma substances SYMRISE GMBH & CO. KG (DE) 2008-03-27 US claimed
EP-1902632-A1 Deconjugated alkadien acid esters as olefactory and or aroma substances Symrise GmbH & Co. KG (DE) 2008-03-26 EP claimed
US-20080076699-A1 Deconjugated alkadienoic acid esters as fragrances and or aroma substances SYMRISE GMBH & CO. KG (DE) 2008-03-27 US disclosed
EP-1902632-A1 Deconjugated alkadien acid esters as olefactory and or aroma substances Symrise GmbH & Co. KG (DE) 2008-03-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076699-A1 Deconjugated alkadienoic acid esters as fragrances and or aroma substances DECR1, ALOX12, ALOX15 MAPT 4488/4885ALDH1A1 21/4885FAAH 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.